IRIS
BARGAGLI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.232
NA - Nord America 12.994
AS - Asia 1.831
OC - Oceania 31
AF - Africa 22
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 9
Totale 29.141
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.892
IT - Italia 3.398
GB - Regno Unito 3.290
IE - Irlanda 3.034
SE - Svezia 1.312
CN - Cina 1.061
FR - Francia 812
UA - Ucraina 754
DE - Germania 601
FI - Finlandia 424
SG - Singapore 198
VN - Vietnam 185
ES - Italia 168
RU - Federazione Russa 149
IN - India 115
CZ - Repubblica Ceca 102
CA - Canada 94
TR - Turchia 50
HK - Hong Kong 44
IR - Iran 38
BE - Belgio 37
AU - Australia 27
JP - Giappone 26
PL - Polonia 24
NL - Olanda 23
KR - Corea 21
PH - Filippine 18
AT - Austria 17
PK - Pakistan 16
PT - Portogallo 13
RO - Romania 11
CH - Svizzera 9
DK - Danimarca 9
EU - Europa 9
MK - Macedonia 7
NG - Nigeria 7
EE - Estonia 6
GR - Grecia 6
MA - Marocco 6
AZ - Azerbaigian 5
BR - Brasile 5
ID - Indonesia 5
KZ - Kazakistan 5
PE - Perù 5
SA - Arabia Saudita 5
AR - Argentina 4
BD - Bangladesh 4
BG - Bulgaria 4
CL - Cile 4
EG - Egitto 4
IS - Islanda 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
MX - Messico 4
NZ - Nuova Zelanda 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
CY - Cipro 3
HU - Ungheria 3
LK - Sri Lanka 3
LT - Lituania 3
LV - Lettonia 3
RS - Serbia 3
CO - Colombia 2
CR - Costa Rica 2
IL - Israele 2
JO - Giordania 2
LU - Lussemburgo 2
QA - Qatar 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
EC - Ecuador 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MM - Myanmar 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 29.141
Salva come PNG Salva come JPEG
Città #
Southend 3.037
Dublin 2.994
Fairfield 2.066
Chandler 1.433
Ashburn 1.149
Woodbridge 879
Seattle 739
Houston 726
Wilmington 693
Siena 634
Cambridge 629
Jacksonville 579
Princeton 473
Ann Arbor 405
Lastra a Signa 325
Helsinki 316
Beijing 261
New York 235
Florence 193
Dong Ket 184
Nanjing 177
Boardman 151
San Diego 150
Dearborn 138
Shanghai 129
San Mateo 127
Moscow 125
Singapore 125
Málaga 124
Rome 103
Milan 100
Fremont 98
London 82
Nanchang 73
Brno 69
Menlo Park 55
Shenyang 50
Washington 50
Gavirate 41
Ottawa 40
Norwalk 39
Catania 37
Brussels 36
Izmir 36
Hebei 33
Guangzhou 32
Redwood City 32
Munich 31
Chicago 30
Hangzhou 30
Olomouc 30
Changsha 29
Los Angeles 29
Kunming 27
Jinan 26
Tarazona 26
Tianjin 26
Jiaxing 25
San Francisco 24
Hong Kong 22
Naples 22
Toronto 22
Lappeenranta 21
Livorno 20
Gießen 19
Düsseldorf 18
Zhengzhou 18
Vienna 17
Padova 16
Prato 16
Zanjan 16
Hefei 15
Seongnam 15
Venezia 15
Arezzo 14
Lancaster 14
Ningbo 14
Bologna 13
Chianciano Terme 13
Hyderabad 13
Paris 13
Pisa 13
Bangalore 12
Central 12
Frankfurt am Main 12
Grosseto 12
Phoenix 12
Aachen 11
Amsterdam 11
Kilburn 11
Trieste 11
Verona 11
Warsaw 11
Comun Nuovo 10
Falkenstein 10
Fuzhou 10
Genoa 10
Mumbai 10
Pasig 10
Pune 10
Totale 21.110
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 951
Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis 305
Cytokine modulators in the treatment of sarcoidosis 217
Gorham-Stout disease management during pregnancy 198
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis 191
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6 189
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 187
Exhaled nitric oxide in interstitial lung diseases 183
Antirheumatic agents in covid-19: is IL-6 the right target? 182
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 180
Peripheral biomarkers' panel for severe COVID-19 patients 179
A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls 176
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 175
Increased Risk of Atherosclerosis in Patients with Sarcoidosis 175
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 174
Genetic mechanisms of critical illness in COVID-19 174
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 172
null 171
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 170
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 170
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? 165
Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity 164
Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress 161
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 161
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 160
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 160
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease 159
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 157
Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): A novel disease phenotype? 156
Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis 156
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline 153
Serum chitotriosidase levels in patients with allergic and non-allergic asthma 150
Quality of life, anxiety and depression in Sarcoidosis 150
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 149
Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes 149
Serum analysis of coagulation factors in IPF and NSIP. 148
NK and NKT-like cells in granulomatous and fibrotic lung diseases 148
Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases 148
null 145
The analysis of tryptase in serum of sarcoidosis patients 143
Tryptase concentrations in bronchoalveolar lavage from patients with chronic eosinophilic pneumonia 143
Phenotypes of organ involvement in sarcoidosis 143
null 143
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 142
Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension 141
Proteome Characterization of BALF Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Unveiling Undercover Molecular Pathways 141
Sarcoidosis: a review for the internist 140
Fibrotic lung toxicity induced by cytotoxic drugs, radiation and immunotherapy in patients treated for lung cancer 139
Oxidative stress in the pathogenesis of diffuse lung diseases: a review 136
Sarcoidosis with upper respiratory tract involvement 136
Fibrotic Lung Toxicity Induced by Hydroxycarbamide 136
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 136
Chromosome 5 inversion in two siblings, one with Klinefelter syndrome and systemic sclerosis, the other with rheumatoid arthritis 135
null 135
Research highlights from the 2018 ERS International Congress: interstitial lung diseases 134
Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre 133
Serum amyloid A in patients with idiopathic pulmonary fibrosis 133
Atypical HRCT manifestations of pulmonary sarcoidosis 132
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors 132
Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity 132
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab 132
Prognostic bioindicators in severe COVID-19 patients 132
Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. 131
Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis 129
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 127
Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis 125
Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases. 125
Extracorporeal Photopheresis in Lung Transplantation 125
Calgranulin B (S100A9/MRP14): a Key molecule in idiopathic pulmonary fibrosis? 124
Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small cell lung cancer: anlysis of risk factors. 123
A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1 123
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 123
null 121
Assessment of cardiac involvement in sarcoidosis by echocardiography 120
Proteomic investigation of pulmonary sarcoidosis 120
Human Chitotriosidase: a sensitive biomarker of sarcoidosis 119
Analysis of trace elements in bronchoalveolar lavage of patients with diffuse lung diseases 119
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 119
Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis 118
The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis 118
Serial KL-6 measurements in COVID-19 patients 117
Idiopathic pulmonary fibrosis [Fibrosi polmonare idiopatica] 116
Immunoglobulin replacement therapy for yellow nail syndrome 116
SARS-CoV-2 in pleural fluid in a kidney transplant patient 116
Serum chitotriosidase activity in sarcoidosis patients 115
Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis 115
Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis 115
New concepts in the pathogenesis of sarcoidosis 115
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 115
null 115
Concentrations of major elements and mercury in unstimulated human saliva 114
Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects 114
M2 marker expression by alveolar macrophages predicts survival in IPF 113
Chitotriosidase activity in patients with interstitial lung disesaes 112
Proteome analysis of bronchoalveolar lavage in pulmonary langerhans cell histiocytosis 112
Proteome analysis of bronchoalveolar lavage in lung diseases 111
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 111
BAL Cell Gene Expression is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis 111
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 111
Pirfenidone in chronic lung allograft dysfunction: a single cohort study 111
Totale 15.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.277 458 169 227 601 311 373 378 517 371 381 160 331
2020/20215.455 198 503 235 694 365 656 317 663 496 375 422 531
2021/20224.491 351 589 368 304 223 157 198 211 186 525 481 898
2022/20235.768 424 592 714 690 419 1.044 359 499 467 207 212 141
2023/20245.671 221 142 526 281 301 1.312 1.689 233 62 185 192 527
2024/2025480 480 0 0 0 0 0 0 0 0 0 0 0
Totale 30.135